Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L- cysteine in HepG2 cells

Drug Metabolism and Drug Interactions

Volumn 21, Issue 1, 2005, Pages 1-18

  Boonyapiwat, Boontarika ^a   Panagopoulos, Panayotis ^a,b   Jones, Hevfin ^c   Mitchell, Stephen C ^c   Forbes, Ben ^a   Steventon, Glyn B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Veterin SA   (Greece)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Enzyme kinetics; HepG2 cells; Phenylalanine 4 monooxygenase; S carboxymethyl L cysteine; S oxidation; Substrate specificity

Indexed keywords

AROMATIC AMINO ACID; CARBOCISTEINE; DEFEROXAMINE; DRUG METABOLITE; ENZYME INHIBITOR; MECYSTEINE; METHIONINE; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TYROSINE;

ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CYTOSOLIC FRACTION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME METABOLISM; HUMAN; HUMAN CELL; LIVER CELL; OXIDATION;

EID: 23744490773     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2005.21.1.1     Document Type: Article

References (33)

1. Poole PJ, Black PN. Oral mucolytic drugs for the exacerbations of chronic obstructive pulmonary disease: systematic review. Br Med J 2001; 322: 1-6.
2. Moore RA, Commins D, Bates G, Phillips CJ. S-Carboxymethylcysteine in the treatment of glue ear: quantitative systematic review. BMC Family Prac 2001; 2: 3 http://www.biomedcentral.eom/1471-2296/2/3
3. Brandolini L, Allegretti M, Berdini V, Cervellera MN, Mascagni P, Rinaldi M, Melillo G, Ghezzi P, Mengozzi M, Bertini R. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur Cytokine Netw 2003; 14: 20-26.
4. Meyer G, Doppierio S, Daffonchio L, Cremaschi D. S-Carboxymethyl- cysteine-lysine salt monohydrate and cAMP cause non-additive activation of the cystic fibrosis transmembrane regulator channel in human respiratory epithelium. FEBS Lett 1997; 404: 11-14.
5. 2-exposed rats. Eur J Pharmacol 2004; 487: 7-15.
6. Ishii Y, Kimura T, Morishima Y, Mochizuki M, Nomura A, Sakamoto T, Uchida Y, Sekizawa K. S-Carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine. Eur J Pharmacol 2002; 449: 183-189.
7. Ndour CT, Ahmed K, Nakagawa T, Nakano Y, Ichinose A, Tarhan G, Aikawa M, Nagatake T. Modulating effects of mucoregulating drugs on the attachment of Haemophilus influenzae. Microb Pathog 2001; 30: 121-127.
8. Cakan G, Turkoz M, Turan T, Ahmed K, Nagatake T. S-Carboxymethyl-cysteine inhibits the attachment of Streptococcus pneumoniae to human pharyngeal epithelial cells. Microb Pathog 2003; 34: 261-265.
9. Brockmoller J, Staffeldt B, Roots I. Evaluation of the proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification. Eur J Pharmacol 1991; 40: 387-392.
10. Hofmann U, Eichelbaum M, Seefried S, Meese CO. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio) lactic acid as major human biotransformation products of S-carboxymethyl-L- cysteine. Drug Metab Dispos 1991; 19: 222-226.
11. Meese CO, Fischer C, Kupfer A, Wisser H, Eichelbaum M. Identification of the "major" polymorphic carbocysteine metabolite as S-(carboxymethylthio)-L-cysteine. Biochem Pharmacol 1991; 42: R13-R16.
12. Mitchell SC, Waring RH, Haley CS, Idle JR, Smith RL. Genetic aspects of the polymodally distributed sulphoxidation S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol 1984; 18: 507-521.
13. Steventon GB. A methodological and metabolite identification study of S-carboxymethyl-L-cysteine metabolism in man. Chromatographia 1998; 48: 561-568.
14. Steventon GB. Diurnal variation in the metabolism of 5-carboxymethyl-L- cysteine in man. Drug Metab Dispos 1999; 27: 1092-1097.
15. Waring RH, Mitchell SC, Idle JR, Smith RL. Genetically determined impaired sulphoxidation. Lancet 1981; i: 778.
16. Haley CS, Waring RH, Mitchell SC, Shah RR, Idle JR, Smith RL. Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population. Xenobiotica 1985; 15: 445-450.
17. Mitchell SC, Waring RH. The deficiency of sulfoxidation of 5-carboxymethyl-L-cysteine. Pharmacol Ther 1989; 43: 237-249.
18. Khan S, Mitchell SC, Steventon GB. Lack of congruence between cysteine dioxygenase activity and 5-carboxymethyl-L-cysteine 5-oxidation activity in rat cytosol. J Pharm Pharmacol 2004; 56: 993-1000.
19. Waring RH, Mitchell SC, Gorman JO, Fraser M. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals. Biochem Pharmacol 1986; 35: 2999-3002.
20. Kaufman S, Mason K. Specificity of amino acids as activators and substrates for phenylalanine hydroxylase. J Biol Chem 1982; 257: 14667-14678.
21. Goreish AH, Bednar S, Jones H, Mitchell SC, Steventon GB. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine. Drug Metab Drug Interact 2004; 20: 159-174.
22. Boonyapiwat B, Forbes B, Steventon GB. Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-L-cysteine. Anal Biochem 2004; 335: 91-97.
23. Meese CO. S-Carboxymethyl-L-Cystein-(R)- und (S)-Sulfoxid. Arch Pharm (Weinheim) 1987; 320: 473-474.
24. Chritensen R, Kolvraa S, Blaese RM, Jensen TG. Development of a skin-based metabolic sink for phenylalanine by the overexpression of phenylalnine hydroxylase and GTP cyclohydrolase in primary human keratinocytes. Gene Therapy 2000; 7: 1971-1978.
25. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
26. Kaufman S. Phenylalnine 4-monooxygenase from rat liver. Meth Enzymol 1987; 142:3-27.
27. Bednar S, Goreish AH, Steventon GB. Use of high-pressure liquid chromatography with fluorescence detection for the in vitro assay of S-carboxymethyl-L-cysteine S-oxygenase. Chromatographia 2004; 59: 237-242.
28. Steventon GB, Sturman S, Waring RH, Williams AC. A review of xenobiotic metabolism enzymes in Parkinson's and motor neuron disease. Drug Metab Drug Interact 2001; 18: 79-98.
29. Bednar S, Steventon GB. Phenylalanine 4-monooxygenase: a susceptibility factor for neurological diseases. J Pharm Pharmacol 2002; 54: S-89.
30. Ledley FD, Grenett, HE, DiLella AG, Kwok SCM, Woo SLC. Gene transfer and expression of human phenylalanine hydroxylase. Science 1985; 228: 77-79.
31. Ledley FD, Grenett, HE, McGinnis-Shelnutt M, Woo SLC. Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells. Proc Natl Acad Sci USA 1986; 83: 409-413.
32. Parsons RB, Ramsden DB, Waring RH, Barber PC, Williams AC. Hepatic localisation of rat cysteine dioxygenase. J Hepatol 1998; 29: 595-602.
33. Ledley FD, Grenett, HE, Woo SLC. Biochemical characterization of recombinant human phenylalanine hydroxylase produced in Escherichia coli. J Biol Chem 1987; 262: 2228-2233.